Inventor · disambiguated record
Anna Skottner
Also filed as: SKOTTNER ANNA
12 granted patents·7 pending applications·191 citations·filing 1988–2013
92Inventor score
Top patents by PatentIndex Score
19 records- 0185US8148429B2Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligandsLUNDSTEDT TORBJOERN·Filed 2006·Granted Apr 3, 2012·7 cites·12 claims
- 0285US5068224AMethod of improving regeneration of transfected peripheral nerves using igf-1KABIVITRUM AB·Filed 1988·Granted Nov 26, 1991·94 cites·6 claims
- 0384US7442807B2N-phenylpyrrole guanidine derivatives as melanocortin receptor ligandsACTION PHARMA AS·Filed 2006·Granted Oct 28, 2008·7 cites·24 claims
- 0476US8410174B2Method for treating arthritisLUNDSTEDT TORBJOERN·Filed 2012·Granted Apr 2, 2013·2 cites·8 claims
- 0576US8309609B2Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligandsLUNDSTEDT TORBJOERN·Filed 2010·Granted Nov 13, 2012·2 cites·2 claims
- 0675US7153881B2Compounds acting as melanocortin receptor ligandsACURE PHARMA AB·Filed 2001·Granted Dec 26, 2006·15 cites·27 claims
- 0773US5434134AUse of human IGF-1 to treat cardiac disordersPHARMAC IA AB·Filed 1992·Granted Jul 18, 1995·32 cites·13 claims
- 0871US7186748B2N-phenylpyrrole guanidine derivatives as melanocortin receptor ligandsACTION PHARMA AS·Filed 2002·Granted Mar 6, 2007·5 cites·19 claims
- 0961US9227927B2Method of treating inflammationANAMAR AB·Filed 2013·Granted Jan 5, 2016·0 cites·9 claims
- 1060US2009018183A1N-phenylpyrrole guanidine derivatives as melanocortin receptor ligandsACTION PHARMA AS·Filed 2008·Application pending·0 cites
- 1158US2007231267A1Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligandsACURE PHARMA AB·Filed 2007·Application pending·0 cites
- 1256US6034059ATreatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrientsCHIRON CORP·Filed 1991·Granted Mar 7, 2000·11 cites·12 claims
- 1354US5994303AUse of insulin and IGF-ICHIRON CORP·Filed 1998·Granted Nov 30, 1999·12 cites·20 claims
- 1451US2004024060A1Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligandsFiled 2001·Application pending·0 cites
- 1545US2004106682A1Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptorsFiled 2002·Application pending·0 cites
- 1645US2004106683A1Uses of benzylideneamino guanidines as ligands to the melnocortin receptorsFiled 2002·Application pending·0 cites
- 1739US5756463AUse of insulin and IGF-1PHARMACIA & UPJOHN AB·Filed 1995·Granted May 26, 1998·4 cites·18 claims
- 1837US2008275129A1Methods and Pharmaceutical Compositions for the Treatment of Neurological DamageACURE PHARMA AB·Filed 2006·Application pending·0 cites
- 1935US2003195212A1Novel melanocortin receptor agonists and antagonistsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna Skottner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →